Editas Medicine Inc (NASDAQ: EDIT) shares fell 5.41%, or $3.36 per share, to close Friday at $58.71. After opening the day at $61.31, shares of Editas Medicine fluctuated between $61.54 and $58.69. 1,171,605 shares traded hands a decrease from their 30 day average of 1,446,043. Friday’s activity brought Editas Medicine’s market cap to $4,007,618,281.
Editas Medicine is headquartered in Cambridge, Massachusetts..
About Editas Medicine Inc
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.
Visit Editas Medicine Inc’s profile for more information.
The Daily Fix
Business software provider Freshworks Inc (Nasdaq: FRSH) soared 32% on its initial public offering Wednesday after pricing above its filing range.
Breakthrough Energy, a non-profit launched by billionaire philanthropist and Microsoft (NASDAQ: MSFT) co-founder Bill Gates in 2016, has raised a warchest from seven leading global corporations to further the organization’s mission of reaching a net-zero emissions society by 2050.
Twitter (NYSE: TWTR) disclosed a binding agreement to settle a consolidated class-action lawsuit, under which the social media company will pay $809.5 million to resolve claims it provided misleading information to investors.
About The Nasdaq Stock Market
The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world’s leading exchange for options volume and is home to the five largest US companies – Apple, Microsoft, Amazon, Alphabet and Facebook.
To get more information on Editas Medicine Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Editas Medicine Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.
Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.
DISCLOSURE:
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: www.equities.com/disclaimer
President Biden Hosting Leaders From India, Japan, Australia Friday in First ‘Quad’ Summit
Some Chinese Banks Stop Offering New Credit to Property Developers Amid Evergrande Scare
Iowa Senator Chuck Grassley Seeks Eighth Term of Office
House Select Committee Subpoenas Four Trump Allies in US Capitol Riot Probe
CDC Endorses COVID-19 Vaccine Booster Shots for Millions of Older and Vulnerable Individuals
Semiconductor Shortage To Cost Global Auto Industry $210 Billion in Revenue in 2021
US Olympic Athletes Must Have COVID-19 Vaccination for Beijing Winter Games
FAA Urges Airlines To Take Stronger Action With Unruly, Disruptive Passengers
Read more here: Source link